Welcome to our dedicated page for TransDigm Group SEC filings (Ticker: TDG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TransDigm Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TransDigm Group's regulatory disclosures and financial reporting.
TransDigm Group Incorporated entered into a definitive agreement to acquire Prince & Izant, a portfolio company of Industrial Growth Partners, for approximately $1.066 billion in cash, including certain tax benefits. Closing is subject to regulatory approvals in the United States and other customary closing conditions.
Prince & Izant, headquartered in Cleveland, designs and manufactures highly engineered brazing alloys and specialty metal components used in advanced, high cost-of-failure applications. It primarily serves aerospace and defense, aeroderivative turbine and transportation markets, derives most revenue from the aftermarket, spans nearly 10,000 active SKUs, and is expected to generate about $360 million in 2026 revenue with roughly 220 employees across four U.S. manufacturing sites. TransDigm’s CEO indicated the deal aligns with the company’s acquisition criteria and long-term private equity-like return objectives.
TransDigm Group Incorporated appointed Irina Krasik to its Board of Directors, effective July 22, 2026. She is a Managing Director at Stellex Capital Management and previously worked at Bregal Investments, The Wicks Group, The Carlyle Group and Merrill Lynch in investment roles.
She also serves on several private-company boards, bringing experience in mergers and acquisitions, investing, corporate strategy and governance. She has not yet been named to any board committees, there are no related person transactions with TransDigm, and she will be paid under the standard non-employee director compensation program described in the 2026 proxy statement.
TransDigm Group executive Joel Reiss, Co-Chief Operating Officer, reported exercising stock options covering 3,900 shares of common stock on July 15, 2026 at an exercise price of $284.97 per share, leaving 11,900 options outstanding. The amended filing corrects the coding of this derivative transaction from an acquisition to a disposition and indicates it was effected under a Rule 10b5-1 trading plan.
TransDigm Group director W. Nicholas Howley reported that his family trust exercised 10,132 stock options for common stock on 2026-07-20 at an exercise price of $66.4700 per share, leaving 11,832 options indirectly held. The trust received 10,132 common shares, then sold 10,132 shares in multiple sale transactions, including 570 shares at $1,210.3242 and 440 shares at $1,224.1377 per share. The filing indicates these transactions were executed under a Rule 10b5-1 trading plan.
TransDigm Group’s Co-Chief Operating Officer Joel Reiss reported selling 414 shares of common stock on July 15, 2026 in multiple open-market or private transactions at prices between $1,229.6600 and $1,233.3800 per share, pursuant to a Rule 10b5-1 trading plan.
TransDigm Group Co-Chief Operating Officer Joel Reiss exercised stock options for 3,900 common shares at $284.97 per share and sold 3,486 shares of common stock on July 15, 2026, in multiple open market or private transactions carried out under a Rule 10b5-1 trading plan.
After these transactions, he directly holds 4,014 TransDigm common shares and 19,700 stock options with a $284.97 exercise price expiring on November 8, 2027.
TransDigm Group Incorporated elected to withdraw from its proposed acquisition of Stellant Systems, Inc. from Arlington Capital Partners. After reviewing the situation, the company concluded that continuing through the regulatory review process was no longer in the best interests of the company and its shareholders, citing uncertainty, the likely time required relative to contractual deadlines, and the opportunity cost versus other strategic acquisitions.
Following TransDigm’s withdrawal of its regulatory filing on July 10, 2026, the seller provided notice of termination of the transaction agreement. TransDigm states that it remains committed to a disciplined acquisition strategy and continues to evaluate opportunities it believes will enhance long-term shareholder value, while reiterating standard forward-looking statement risk disclosures.
TransDigm Group director W. Nicholas Howley reported an amended insider filing reflecting an “other” type transaction with no change in share ownership. The filing shows 0 common shares were transacted and 21,547.513 shares are held indirectly through the W. Nicholas Howley Family Trust u/a/d 4/23/99.
TransDigm Group director W. Nicholas Howley, through his family trust, reported an exercise-and-sell transaction in company stock. On June 18, 2026, the W. Nicholas Howley Family Trust exercised 10,132 stock options at an exercise price of $66.47 per share and acquired the same number of common shares.
The trust then sold 10,132 shares of TransDigm common stock in multiple open-market trades, at prices ranging from approximately $1,305 to $1,337.06 per share. Following these transactions, the trust’s indirect holdings in TransDigm common stock were 21,547.513 shares.
TransDigm Group INC director W. Nicholas Howley reported coordinated option exercises and share sales through his family trust. On June 18, 2026, the W. Nicholas Howley Family Trust u/a/d 4/23/99 exercised stock options for 10,132 shares of TransDigm common stock at an exercise price of $66.47 per share and sold 10,132 common shares in multiple open-market transactions.
The reported sale prices ranged around $1,305–$1,337 per share, with each line item giving a weighted average price for trades within a specific band. Following these transactions, the trust indirectly holds 21,547.513 shares of TransDigm common stock.